跳至主要内容
临床试验/NCT00000299
NCT00000299已完成2 期

Rapid Opiate Detoxification & Naltrexone Induction Using Bup.

University of California, Los Angeles1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Opiate withdrawal symptoms

研究概览

简要总结

The purpose of this study is to develop a clinical protocol to detoxify patients from opiates to naltrexone using buprenorphine and to develop pilot data for a grant application for a controlled study of the efficacy of the new clinical protocol for outpatients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males/Females, ages 21-
  • Opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.

排除标准

  • psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependent on etoh or benzodiazepines or other sedative-hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.

研究组 & 干预措施

buprenorphine

Active Comparator

depot buprenorphine

干预措施: Buprenorphine (Drug)

buprenorphine and ultra-low dose naloxone

Experimental

depot buprenorphine and naloxone

干预措施: Buprenorphine (Drug)

结局指标

主要结局

Opiate withdrawal symptoms

时间窗: 10 test days

opiate withdrawal symptoms are documented for each test day

Opiate craving

时间窗: 10 test days

opiate craving is measured on each test day.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Walter Ling

PI

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验

Rapid Opiate Detoxification and Naltrexone Induction... | 临床试验